1.
|
Phase: Phase IV Type: Treatment Status: Completed Age: 15 to 65 Sponsor: Other Protocol IDs: GMALL03, NCT00199004
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Completed Age: 15 to 65 Sponsor: Other Protocol IDs: GMALL04, NCT00199017
|
|
3.
|
Phase: Phase III Type: Treatment Status: Completed Age: 16 and over Sponsor: Other Protocol IDs: AMLCG 99, BMBF 01 GI 02070, NCT00266136
|
|
4.
|
Phase: Phase III Type: Treatment Status: Closed Age: Under 4 at diagnosis Sponsor: NCI, Other Protocol IDs: CDR0000492776, COG-AAML0431, AAML0431, NCT00369317
|
|
5.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: ID03-0124, NCT00452439
|
|
6.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 2007-003103-12, NCT01382147
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 to 55 Sponsor: Other Protocol IDs: 9L-03-1, NCT00184041
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: 12 and over Sponsor: Other Protocol IDs: 2003-0600, NCT00504660
|
|
9.
|
Phase: Phase II Type: Treatment Status: Completed Age: 15 to 65 Sponsor: NCI, Other Protocol IDs: CDR0000064250, SWOG-9400, U10CA032102, NCT00002665
|
|
10.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 1 to 30 Sponsor: NCI, Other Protocol IDs: AALL07P4, CDR0000594340, NCI-2009-00317, COG-AALL07P4, NCT00671034
|
|
11.
|
Phase: No phase specified Type: Treatment Status: Closed Age: 1 to 30 at diagnosis Sponsor: NCI, Other Protocol IDs: CDR0000636174, COG-AALL08P1, AALL08P1, NCT00866307
|